Brief Interventions in Chronic Migraine
Launched by UNIVERSITY OF MICHIGAN · Jul 28, 2023
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how changing certain behaviors can help people who suffer from chronic migraines. Chronic migraines are severe headaches that can happen frequently and make it difficult for individuals to carry out their daily activities, sleep well, or feel good emotionally. The trial will explore whether two specific programs—Empowered Relief and Health Education—can reduce the disability caused by migraines and help lessen the pain and emotional distress related to these headaches.
To participate, you need to be at least 18 years old, speak English, and have a diagnosis of chronic migraine from a neurologist. You should also have internet access for remote meetings. If you join the study, you will be randomly assigned to one of the two programs and will not need to meet in person. The researchers hope to see improvements in your migraine symptoms one month after completing the program, and they will check back with you at two, three, and six months to see if those improvements last. This study aims to find better ways to help people manage chronic migraines and improve their quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Self-reported neurologist diagnosis of chronic migraine
- • Meets diagnostic criteria for chronic migraine according to the Identify Chronic Migraine (IDCM) self-reported instrument
- • English-speaking
- • Internet access and audio-visual conferencing capability (e.g., Zoom meetings by phone or computer) in the home
- • Age 18 years or older
- Exclusion Criteria:
- • Currently receiving cognitive-behavioral therapy for pain or migraine
- • Open litigation regarding a medical condition, as assessed in preliminary study screening
- • Inability to provide informed consent and complete study procedures (e.g., indications of suspected major cognitive impairment via observations of study staff during consenting) that would preclude comprehension or participation in study protocols
- • Failure to complete at least 7 out of 14 pre-intervention daily diaries
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
John Sturgeon, PhD
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported